These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16210695)

  • 1. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages.
    Armstrong L; Godinho SI; Uppington KM; Whittington HA; Millar AB
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):219-25. PubMed ID: 16210695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.
    Armstrong L; Godinho SI; Uppington KM; Whittington HA; Millar AB
    Clin Exp Immunol; 2009 May; 156(2):336-43. PubMed ID: 19292764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
    Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
    Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism.
    Brennan FM; Green P; Amjadi P; Robertshaw HJ; Alvarez-Iglesias M; Takata M
    Eur J Immunol; 2008 Apr; 38(4):1106-17. PubMed ID: 18383040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
    Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR
    Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
    Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
    PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation.
    Rovida E; Paccagnini A; Del Rosso M; Peschon J; Dello Sbarba P
    J Immunol; 2001 Feb; 166(3):1583-9. PubMed ID: 11160199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia.
    Maus U; Rosseau S; Knies U; Seeger W; Lohmeyer J
    Eur Respir J; 1998 Mar; 11(3):534-41. PubMed ID: 9596098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells.
    Obeid D; Nguyen J; Lesavre P; Bauvois B
    Oncogene; 2007 Jan; 26(1):102-10. PubMed ID: 16799629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma down-regulates expression of tumor necrosis factor-alpha converting enzyme/a disintegrin and metalloproteinase 17 in activated hepatic stellate cells of rats.
    Fujita T; Maesawa C; Oikawa K; Nitta H; Wakabayashi G; Masuda T
    Int J Mol Med; 2006 Apr; 17(4):605-16. PubMed ID: 16525716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage.
    Kermarrec N; Selloum S; Plantefeve G; Chosidow D; Paoletti X; Lopez A; Mantz J; Desmonts JM; Gougerot-Pocidalo MA; Chollet-Martin S
    Crit Care Med; 2005 Jun; 33(6):1359-64. PubMed ID: 15942356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells.
    Peiretti F; Canault M; Bernot D; Bonardo B; Deprez-Beauclair P; Juhan-Vague I; Nalbone G
    J Cell Sci; 2005 Mar; 118(Pt 5):1061-70. PubMed ID: 15731011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.
    Freeburn RW; Armstrong L; Millar AB
    Eur Cytokine Netw; 2005; 16(1):5-16. PubMed ID: 15809201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
    Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.